Carmichael Hill & Associates, Inc. Seelos Therapeutics, Inc. Transaction History

Carmichael Hill & Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$0.16 - $1.64 $1,600 - $16,400	10,000 Added 47.62%	31,000 $5,000
Q1 2023 Apr 05, 2023	BUY	$0.59 - $1.04 $5,900 - $10,400	10,000 Added 90.91%	21,000 $14,000
Q3 2022 Nov 10, 2022	BUY	$0.65 - $1.41 $1,300 - $2,820	2,000 Added 22.22%	11,000 $11,000
Q2 2022 Aug 05, 2022	BUY	$0.51 - $0.93 $1,530 - $2,790	3,000 Added 50.0%	9,000 $6,000
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $2,100 - $4,275	2,500 Added 71.43%	6,000 $5,000

Q4 2021 Jan 31, 2022	BUY	$1.59 - $2.38 $2,385 - $3,570	1,500 Added 75.0%	3,500 $6,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $3,380 - $5,780	2,000 New	2,000 $5,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.